Volume 26 - Issue 10 - October 2018

Results from a recent study highlighted the benefits and harms of omalizumab among patients with chronic idiopathic urticaria.
Dr Golda
Section Editor, Benjamin Barankin, MD, FRCPC
geriatric care
Eileen Koutnik-Fotopoulos, Contributing Editor
Melissa Weiss, Associate Editor
pustular psoriasis in pregnancy
Aretina Leung; Jad Saab, MD; Horatio F. Wildman, MD; and Cynthia Magro, MD
misdiagnosed psoriasis
Adam J Carter, MD; Kristyna Lee, MD, MPH; and Arlene Rogachefsky, MD